- Home
- WKC vs SLNO Comparison
WKC vs SLNO Comparison
Compare WKC & SLNO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WKC
- SLNO
- Stock Information
- Founded
- WKC 1984
- SLNO 1999
- Country
- WKC United States
- SLNO United States
- Employees
- WKC N/A
- SLNO N/A
- Industry
- WKC Oil Refining/Marketing
- SLNO Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- WKC Energy
- SLNO Health Care
- Exchange
- WKC Nasdaq
- SLNO Nasdaq
- Market Cap
- WKC 1.7B
- SLNO 1.9B
- IPO Year
- WKC N/A
- SLNO 2014
- Fundamental
- Price
- WKC $29.00
- SLNO $52.63
- Analyst Decision
- WKC Hold
- SLNO Strong Buy
- Analyst Count
- WKC 5
- SLNO 7
- Target Price
- WKC $28.00
- SLNO $67.14
- AVG Volume (30 Days)
- WKC 623.6K
- SLNO 611.7K
- Earning Date
- WKC 10-24-2024
- SLNO 11-05-2024
- Dividend Yield
- WKC 2.35%
- SLNO N/A
- EPS Growth
- WKC 20.89
- SLNO N/A
- EPS
- WKC 2.25
- SLNO N/A
- Revenue
- WKC $46,164,900,000.00
- SLNO N/A
- Revenue This Year
- WKC N/A
- SLNO N/A
- Revenue Next Year
- WKC $4.49
- SLNO N/A
- P/E Ratio
- WKC $12.89
- SLNO N/A
- Revenue Growth
- WKC N/A
- SLNO N/A
- 52 Week Low
- WKC $17.69
- SLNO $3.96
- 52 Week High
- WKC $29.16
- SLNO $54.09
- Technical
- Relative Strength Index (RSI)
- WKC 58.31
- SLNO 60.12
- Support Level
- WKC $27.62
- SLNO $48.38
- Resistance Level
- WKC $29.16
- SLNO $54.09
- Average True Range (ATR)
- WKC 0.54
- SLNO 2.49
- MACD
- WKC -0.01
- SLNO 0.35
- Stochastic Oscillator
- WKC 70.69
- SLNO 82.47
About WKC World Kinect Corporation
World Kinect Corp is a energy management company involved in providing supply fulfillment, energy procurement advisory services, and transaction and payment management solutions to commercial and industrial customers . It sells and delivers liquid fuels, natural gas, electricity, renewable energy, and other sustainability solutions. Company operate in three reportable segments consisting of aviation, land, and marine. Company earn majority of revenue from Aviation segment.
About SLNO Soleno Therapeutics Inc.
Soleno Therapeutics Inc is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its product candidates comprise Diazoxide Choline Controlled-Release tablets, which is an oral tablet for the treatment of Prader-Willi Syndrome. DCCR tablets consist of the active ingredient diazoxide choline, a choline salt of diazoxide, which is a benzothiadiazine.